Cargando…

Antiviral effects of oleandrin

Detalles Bibliográficos
Autores principales:	Newman, R., Jagannadha Sastry, K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188805/ https://www.ncbi.nlm.nih.gov/pubmed/34142105 http://dx.doi.org/10.1002/emp2.12469

Ejemplares similares

Antiviral Effects of Oleandrin
por: Newman, Robert A, et al.
Publicado: (2020)

Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2
por: Plante, Kenneth S., et al.
Publicado: (2021)

Efficacy of oleandrin and PBI-05204 against bovine viruses of importance to commercial cattle health
por: Newman, Robert A., et al.
Publicado: (2022)

The Botanical Glycoside Oleandrin Inhibits Human T-cell Leukemia Virus Type-1 Infectivity and Env-Dependent Virological Synapse Formation
por: Hutchison, Tetiana, et al.
Publicado: (2019)

Oleandrin: A cardiac glycosides with potent cytotoxicity
por: Kumar, Arvind, et al.
Publicado: (2013)

The effect of 5α-oleandrin on keloid fibroblast activities
por: Dachlan, Ishandono, et al.
Publicado: (2019)

Retraction: Oleandrin: A Cardiac Glycosides with Potent Cytotoxicity
Publicado: (2016)

Regulation of Intrinsic and Extrinsic Apoptotic Pathways in Osteosarcoma Cells Following Oleandrin Treatment
por: Ma, Yunlong, et al.
Publicado: (2016)

Oleandrin induces DNA damage responses in cancer cells by suppressing the expression of Rad51
por: Bao, Zhengqiang, et al.
Publicado: (2016)

Cytotoxicity of Oleandrin Is Mediated by Calcium Influx and by Increased Manganese Uptake in Saccharomyces cerevisiae Cells
por: Ruta, Lavinia L., et al.
Publicado: (2020)

Differential Activities of the Botanical Extract PBI-05204 and Oleandrin on Innate Immune Functions under Viral Challenge Versus Inflammatory Culture Conditions
por: Jensen, Gitte S., et al.
Publicado: (2023)

Oleandrin: A Systematic Review of its Natural Sources, Structural Properties, Detection Methods, Pharmacokinetics and Toxicology
por: Zhai, Jinxiao, et al.
Publicado: (2022)

Putative antiviral effects of propofol in COVID-19
por: Wei, Penghui, et al.
Publicado: (2021)

Inhibition of oleandrin on the proliferation show and invasion of osteosarcoma cells in vitro by suppressing Wnt/β-catenin signaling pathway
por: Ma, Yunlong, et al.
Publicado: (2015)

Oleandrin synergizes with cisplatin in human osteosarcoma cells by enhancing cell apoptosis through activation of the p38 MAPK signaling pathway
por: Yong, Lei, et al.
Publicado: (2018)

Combining immunomodulators and antivirals for COVID-19
por: Chen, Luke Y C, et al.
Publicado: (2021)

Oleandrin and Its Derivative Odoroside A, Both Cardiac Glycosides, Exhibit Anticancer Effects by Inhibiting Invasion via Suppressing the STAT-3 Signaling Pathway
por: Ko, Young Shin, et al.
Publicado: (2018)

Rationale of receptor-based antivirals against SARS
Publicado: (2013)

Early triple antiviral therapy for COVID-19
por: Lee, Nelson, et al.
Publicado: (2020)

Combining immunomodulators and antivirals for COVID-19 – Authors' reply
por: Almansa, Raquel, et al.
Publicado: (2021)

Modelling the evolution of drug resistance in the presence of antiviral drugs
por: Wu, Jianhong, et al.
Publicado: (2007)

Metabolomics to Predict Antiviral Drug Efficacy in COVID-19
por: Migaud, Marie, et al.
Publicado: (2020)

Functional exhaustion of antiviral lymphocytes in COVID-19 patients
por: Zheng, Meijuan, et al.
Publicado: (2020)

Host-targeting oral antiviral drugs to prevent pandemics
por: Dwek, Raymond A, et al.
Publicado: (2022)

Cyclosporin A Reveals Potent Antiviral Effects in Preclinical Models of SARS-CoV-2 Infection
por: Sauerhering, Lucie, et al.
Publicado: (2022)

Early triple antiviral therapy for COVID-19 – Authors' reply
por: Hung, Ivan Fan-Ngai, et al.
Publicado: (2020)

Uptake of monoclonal antibodies and antiviral therapies for COVID-19 in Scotland
por: Tibble, Holly, et al.
Publicado: (2023)

WHO Living Guidelines on antivirals for COVID-19 are evidence-based
por: Owen, Andrew, et al.
Publicado: (2023)

One-year clinical outcomes of different coronary drug eluting stents—Data from a prospective registry
por: Sastry, B.K.S., et al.
Publicado: (2018)

Clinical management, antiviral drugs and immunotherapeutics for treating monkeypox. An update on current knowledge and futuristic prospects
por: Chakraborty, Sandip, et al.
Publicado: (2022)

Antiviral treatment of COVID-19: which role can clinical parameters play in therapy evaluation?
por: Hübner, Yannis R., et al.
Publicado: (2023)

The Hygiene Hypothesis and Its Inconvenient Truths about Helminth Infections
por: Briggs, Neima, et al.
Publicado: (2016)

Author's overview: identifying SARS-CoV-2 antiviral compounds
por: Diffley, John F.X.
Publicado: (2021)

Direct-acting antivirals for acute hepatitis C in HIV-infected MSM
por: Millard, James Daniel, et al.
Publicado: (2016)

Reply to: “Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19”
por: Nicolini, Laura Ambra, et al.
Publicado: (2020)

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant
por: Takashita, Emi, et al.
Publicado: (2022)

Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75
por: Takashita, Emi, et al.
Publicado: (2022)

Efficacy of antivirals and mRNA vaccination against an XBF clinical isolate
por: Uraki, Ryuta, et al.
Publicado: (2023)

Monkeypox treatment options: current status of antiviral drugs – a correspondence
por: Ganapthy, Dhanraj, et al.
Publicado: (2023)

A Probable Fatal Case of Oleander (Nerium oleander) Poisoning on a Cattle Farm: A New Method of Detection and Quantification of the Oleandrin Toxin in Rumen
por: Rubini, Silva, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7k569lc716kccm7n7lg43h2bio